H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings Inc. (hereinafter “Fujirebio”) today announced that Fujirebio Diagnostics, Inc., a subsidiary of Fujirebio, has acquired all shares of Plasma Services Group,...

The new site, which specializes in early-phase development and manufacturing services with an experienced team of more than 80 employees, is set to strengthen Siegfried’s customer offering for Drug Substances in terms of capabilities.

A4P is headquartered in Discovery Park, Sandwich, Kent, UK, with a wholly-owned subsidiary in Appenzell, Switzerland. With core expertise in regulated bioanalysis and genomics, biomarker strategy, personalized healthcare, biosample operations…

Reverba’s acquisition will enable the integration of Six Degrees’ comprehensive suite of medical communication services into its innovative patient engagement approach and platforms. This synergy will simplify the delivery of complex…

Bio X Cell is a leading producer of monoclonal antibodies (mAbs) for use in both in vivo and in vitro pre-clinical research applications. Founded by Dr. Klaus Lubbe in 1997 as a contract manufacturer of antibodies.

Achelous, a leading advisory firm specializing in mergers and acquisitions, has successfully facilitated the strategic sales of Symbio and ProInnovera to Archimed, a prominent global private equity firm.

Global Private Equity healthcare specialist ARCHIMED has acquired and simultaneously merged US-based Symbio, and Germany-based Proinnovera in all-equity deal.

Achelous, a leading M&A advisory firm, is pleased to announce its role in advising Pharmalog on its sale to Henko Partners, a prominent investment firm. This transaction will result in the creation of Astrum, a new company poised to become a...

Henko Partners launches AstrumCRO after investing in BlueClinical and Pharmalog